The current study has some limitations: Firstly, the Mdr2 −/− model, although advantageous in its ability to capture important phases of inflammation associated HCC development, is not an inducible model, thus making it difficult to ascertain whether microbiome perturbations were as a result of liver disease or vice versa. The gene discussed is ABCB4; the disease is liver disorder.